X
25Jan

Financial Daily Dose 1.25.2021 | Top Story: Merck Abandons Covid Vaccine Effort Over Ineffective Results

U.S. drug giant Merck is shuttering its coronavirus vaccine development “after early trial data showed [its pair of vaccines] failed to generate immune responses comparable to natural infection or existing vaccines.”...
By: Robins Kaplan LLP
Source Url: https://www.jdsupra.com/legalnews/financial-daily-dose-1-25-2021-top-6427012/

Related

Health Sector Does Not Completely Avoid the CCPA by HIPAA Exemption (4 Months to Go)

Don’t wait to implement your California Consumer Privacy Act (CCPA) compliance as it could require ...

Read More >

Utah Affirms Again – Implied Covenants, Even Good Faith and Fair Dealing, Do Not Trump Express Covenants

On October 29, 2019, the Utah Supreme Court issued a rare decision reversing the Utah Court of Appea...

Read More >

SBA Clarifies Rules Regarding PPP Loans And Changes Of Ownership

In a recently issued procedural notice, the Small Business Association (“SBA”) addressed a lingeri...

Read More >

How to deal with data protection and network security issues in M&A operations in the Asia-Pacific region

In recent years, the Asia-Pacific region has been the central hub of M&A activities. Even in 2020, w...

Read More >

SB 330 Seeks to Speed Up Housing Production

The Housing Crisis Act of 2019 (Senate Bill No. 330; Senator Skinner) goes into effect on January 1,...

Read More >

Alert: Will COVID-19 Impact Antitrust Review of M&A Deals and How Can Parties Minimize Disruption?

Antitrust FAQs for Merging Parties - What modifications have the FTC and DOJ made for transactions ...

Read More >